title: Gender specific issues in hereditary ocular disorders.
abstract: This review is intended to summarize the current knowledge from basic science and clinical medical literature cited within PubMed that pertain to gender-related factors and affect those individuals with hereditary ocular disorders. We consider gender-related biological factors that (a) affect disease onset and progression, (b) gender differences for major X-linked ocular disorders, (c) gender-specific conditions, (d) medications that may influence genetic eye disorders, and finally, (e) gender-related issues that influence the management and quality of life of these patients. Several studies have demonstrated the manner in which sex-related hormones in animal models are capable of influencing cell pathway and survival that are likely to affect hereditary eye disorders. There are very few clinical studies that provide compelling evidence for gender differences in human ocular conditions, other than for a number of X-linked disorders. Disease expression for X-linked disorders may be impacted by genetic mechanisms such as lyonization or uniparental disomy. Clinical evidence regarding the impact of gender-related medical conditions and therapies on eye conditions is extremely limited and primarily based on anecdotal evidence. Gender-specific factors may play a major role in the underlying biological pathways that influence the onset, rate of progression, and clinical findings associated with ocular genetic conditions. Clinicians need to be aware of the variable phenotypes observed in female carriers of X-linked disorders of gender specific issues, many of which are inadequately addressed in the current literature. Clinicians need to be sensitive to gender differences in social, cultural, and religious systems and they should also be aware of how their own gender biases may influence how they counsel patients. Finally, it is clear that the lack of effective clinical studies in this area creates an opportunity for future research that will have real benefits for these patients.
authors.affiliation: Department of Ophthalmology , UCLA, Los Angeles, CA , USA and.
authors.forename: Saradha
authors.initials: S
authors.lastname: Iragavarapu
authors.forename: Michael B
authors.initials: MB
authors.lastname: Gorin
mesh_terms: D000728:Androgens / Q000502:physiology; D018450:Disease Progression; D004967:Estrogens / Q000502:physiology; D015785:Eye Diseases, Hereditary / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D040181:Genetic Diseases, X-Linked / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008297:Male; D018384:Oxidative Stress; D011247:Pregnancy; D011248:Pregnancy Complications; D012737:Sex Factors
chemical_list: D000728:Androgens; D004967:Estrogens
keywords: Gender; hereditary ocular disorders; hormones